Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as Intracranial Hypertension
A Case Report
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received December 5, 2021
- Accepted in final form June 27, 2022
- First Published October 19, 2022.
Author Disclosures
- Jaydip Ray Chaudhuri, MD, DM, FEBN, MRCP,
- Jui Jade Bagul, MD, DM (juijade{at}yahoo.co.in),
- Alluri Swathi, MBBS, MRCP (alluriswathi.asd{at}gmail.com),
- Bhim Sen Singhal, MD, DSC, FRCP, FCCP, FAMS (bssinghal{at}gmail.com),
- N. Chakradhar Reddy, DM (chakri9951{at}gmail.com) and
- Kiran Kumar Vallam, DO, MRCS (drraoyashoda{at}gmail.com)
- Jaydip Ray Chaudhuri, MD, DM, FEBN, MRCP,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Jui Jade Bagul, MD, DM (juijade{at}yahoo.co.in),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Alluri Swathi, MBBS, MRCP (alluriswathi.asd{at}gmail.com),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Bhim Sen Singhal, MD, DSC, FRCP, FCCP, FAMS (bssinghal{at}gmail.com),
None
NONE
Chairing MS related meeting of Eisai in India during COVID period - commercial entity, honorarium 2. Novartis, commercial, honorarium, Chair of educational session on Multiple Sclerosis
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- N. Chakradhar Reddy, DM (chakri9951{at}gmail.com) and
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Kiran Kumar Vallam, DO, MRCS (drraoyashoda{at}gmail.com)
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- From the Yashoda Hospital (J.R.C., A.S., N.C.R., K.K.V.), Hyderabad; and Bombay Hospital Institute of Medical Science (J.J.B., B.S.S.), India.
- Correspondence
Dr. Chaudhuri jaydiprc{at}gmail.com
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.